Taiwan Drug Market Dominated By Cancer Drugs, Research Shows
This article was originally published in PharmAsia News
Executive Summary
Taiwan counts drugs for treating cancer, cholesterol, hypertension and diabetes as top sellers, six of the top 20 for cancer alone
|
Taiwan counts drugs for treating cancer, cholesterol, hypertension and diabetes as top sellers, six of the top 20 for cancer alone. The count was conducted by the U.S.-based research firm, IMS Health. The other three leading drugs combined for another six of the top 20. Taiwan's largest-selling drug is U.S.-based Pfizer's amlogipine, sold in Taiwan as Navasc for treating high blood pressure. Cancer drugs are expected to dominate even more of the best-sellers in coming years, comprising half of the top 20 over the next decade, one expert said. (Click here for more) "Cancer, Cholesterol Drugs Among Top Sellers In Taiwan" - Taipei Times (Taiwan) (3/29/10) |